BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20536741)

  • 1. Lymphatic dysfunction, not aplasia, underlies Milroy disease.
    Mellor RH; Hubert CE; Stanton AW; Tate N; Akhras V; Smith A; Burnand KG; Jeffery S; Mäkinen T; Levick JR; Mortimer PS
    Microcirculation; 2010 May; 17(4):281-96. PubMed ID: 20536741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in FOXC2 in humans (lymphoedema distichiasis syndrome) cause lymphatic dysfunction on dependency.
    Mellor RH; Tate N; Stanton AW; Hubert C; Mäkinen T; Smith A; Burnand KG; Jeffery S; Levick JR; Mortimer PS
    J Vasc Res; 2011; 48(5):397-407. PubMed ID: 21464574
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Liu N; Gao M
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare Variants in LAMA5 Gene associated with FLT4 and FOXC2 Mutations in Primary Lymphedema May Contribute to Severity.
    Liu NF; Yu ZY; Sun D; Lou Y
    Lymphology; 2016 Dec; 49(4):192-204. PubMed ID: 29908552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.
    Gordon K; Schulte D; Brice G; Simpson MA; Roukens MG; van Impel A; Connell F; Kalidas K; Jeffery S; Mortimer PS; Mansour S; Schulte-Merker S; Ostergaard P
    Circ Res; 2013 Mar; 112(6):956-60. PubMed ID: 23410910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases.
    Monaghan RM; Page DJ; Ostergaard P; Keavney BD
    Cardiovasc Res; 2021 Jul; 117(8):1877-1890. PubMed ID: 33067626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cutaneous lymphatic network in the forearms of women with postmastectomy oedema.
    Mellor RH; Stanton AW; Azarbod P; Sherman MD; Levick JR; Mortimer PS
    J Vasc Res; 2000; 37(6):501-12. PubMed ID: 11146404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas.
    Connell FC; Ostergaard P; Carver C; Brice G; Williams N; Mansour S; Mortimer PS; Jeffery S;
    Hum Genet; 2009 Jan; 124(6):625-31. PubMed ID: 19002718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunction of dermal initial lymphatics of the arm and upper body quadrant causes congenital arm lymphedema.
    Liu N; Gao M; Yu Z
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):482-488. PubMed ID: 32599305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel FLT4 mutation identified in a patient with Milroy disease.
    DiGiovanni RM; Erickson RP; Ohlson EC; Bernas M; Witte MH
    Lymphology; 2014 Mar; 47(1):44-7. PubMed ID: 25109169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in the conserved sequence of vascular endothelial growth factor receptor 3 leads to primary lymphoedema.
    Dai T; Li B; He B; Yan L; Gu L; Liu X; Qi J; Li P; Zhou X
    J Int Med Res; 2018 Aug; 46(8):3162-3171. PubMed ID: 29896974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation.
    Ghalamkarpour A; Holnthoner W; Saharinen P; Boon LM; Mulliken JB; Alitalo K; Vikkula M
    J Med Genet; 2009 Jun; 46(6):399-404. PubMed ID: 19289394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb.
    Mellor RH; Brice G; Stanton AW; French J; Smith A; Jeffery S; Levick JR; Burnand KG; Mortimer PS;
    Circulation; 2007 Apr; 115(14):1912-20. PubMed ID: 17372167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milroy's primary congenital lymphedema in a male infant and review of the literature.
    Kitsiou-Tzeli S; Vrettou C; Leze E; Makrythanasis P; Kanavakis E; Willems P
    In Vivo; 2010; 24(3):309-14. PubMed ID: 20555004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of venous and lymphatic congestion on lymph capillary pressure of the skin in healthy volunteers and patients with lymph edema.
    Gretener SB; Läuchli S; Leu AJ; Koppensteiner R; Franzeck UK
    J Vasc Res; 2000; 37(1):61-7. PubMed ID: 10720887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel VEGFR3 mutation causes Milroy disease.
    Butler MG; Dagenais SL; Rockson SG; Glover TW
    Am J Med Genet A; 2007 Jun; 143A(11):1212-7. PubMed ID: 17458866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoprostane 8-epi-prostaglandin F2 alpha decreases lymph capillary pressure in patients with primary lymphedema.
    Amann-Vesti BR; Gitzelmann G; Koppensteiner R; Franzeck UK
    J Vasc Res; 2003; 40(1):77-82. PubMed ID: 12644728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired lymphatic function recovered after great saphenous vein stripping in patients with varicose vein: venodynamic and lymphodynamic results.
    Suzuki M; Unno N; Yamamoto N; Nishiyama M; Sagara D; Tanaka H; Mano Y; Konno H
    J Vasc Surg; 2009 Nov; 50(5):1085-91. PubMed ID: 19632804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A NOVEL FLT4 GENE MUTATION AND MR LYMPHANGIOGRAPHY IN A CHINESE FAMILY WITH MILROY DISEASE.
    Liu NF; Yu Z; Luo Y; Sun D; Yan Z
    Lymphology; 2015 Jun; 48(2):93-6. PubMed ID: 26714373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence microlymphography: diagnostic potential in lymphedema and basis for the measurement of lymphatic pressure and flow velocity.
    Bollinger A; Amann-Vesti BR
    Lymphology; 2007 Jun; 40(2):52-62. PubMed ID: 17853615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.